108 related articles for article (PubMed ID: 9351646)
1. Modulation of rat brain cannabinoid receptors after chronic morphine treatment.
Rubino T; Tizzoni L; Viganò D; Massi P; Parolaro D
Neuroreport; 1997 Oct; 8(15):3219-23. PubMed ID: 9351646
[TBL] [Abstract][Full Text] [Related]
2. Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions.
Romero J; Garcia-Palomero E; Castro JG; Garcia-Gil L; Ramos JA; Fernandez-Ruiz JJ
Brain Res Mol Brain Res; 1997 Jun; 46(1-2):100-8. PubMed ID: 9191083
[TBL] [Abstract][Full Text] [Related]
3. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol.
Romero J; Berrendero F; García-Gil L; Ramos JA; Fernández-Ruiz JJ
J Mol Neurosci; 1998 Oct; 11(2):109-19. PubMed ID: 10096037
[TBL] [Abstract][Full Text] [Related]
4. Time-dependent differences of repeated administration with Delta9-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by mu-opioid and CB1-cannabinoid receptors in the caudate-putamen.
Corchero J; Romero J; Berrendero F; Fernandez-Ruiz J; Ramos JA; Fuentes JA; Manzanares J
Brain Res Mol Brain Res; 1999 Apr; 67(1):148-57. PubMed ID: 10101241
[TBL] [Abstract][Full Text] [Related]
5. Effects of long-term exposure to delta9-THC on expression of cannabinoid receptor (CB1) mRNA in different rat brain regions.
Zhuang S; Kittler J; Grigorenko EV; Kirby MT; Sim LJ; Hampson RE; Childers SR; Deadwyler SA
Brain Res Mol Brain Res; 1998 Nov; 62(2):141-9. PubMed ID: 9813289
[TBL] [Abstract][Full Text] [Related]
6. Time-course of the cannabinoid receptor down-regulation in the adult rat brain caused by repeated exposure to delta9-tetrahydrocannabinol.
Romero J; Berrendero F; Manzanares J; Pérez A; Corchero J; Fuentes JA; Fernández-Ruiz JJ; Ramos JA
Synapse; 1998 Nov; 30(3):298-308. PubMed ID: 9776133
[TBL] [Abstract][Full Text] [Related]
7. The enhancement of morphine antinociception in mice by delta9-tetrahydrocannabinol.
Smith FL; Cichewicz D; Martin ZL; Welch SP
Pharmacol Biochem Behav; 1998 Jun; 60(2):559-66. PubMed ID: 9632241
[TBL] [Abstract][Full Text] [Related]
8. Adolescent exposure to chronic delta-9-tetrahydrocannabinol blocks opiate dependence in maternally deprived rats.
Morel LJ; Giros B; Daugé V
Neuropsychopharmacology; 2009 Oct; 34(11):2469-76. PubMed ID: 19553915
[TBL] [Abstract][Full Text] [Related]
9. Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems.
Solinas M; Goldberg SR
Neuropsychopharmacology; 2005 Nov; 30(11):2035-45. PubMed ID: 15812567
[TBL] [Abstract][Full Text] [Related]
10. Involvement of cannabinoid (CB1)-receptors in the development and maintenance of opioid tolerance.
Trang T; Sutak M; Jhamandas K
Neuroscience; 2007 May; 146(3):1275-88. PubMed ID: 17395382
[TBL] [Abstract][Full Text] [Related]
11. Two distinctive antinociceptive systems in rats with pathological pain.
Mao J; Price DD; Lu J; Keniston L; Mayer DJ
Neurosci Lett; 2000 Feb; 280(1):13-6. PubMed ID: 10696800
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of morphine tolerance and dependence by diazepam and its relation to mu-opioid receptors in the rat brain and spinal cord.
Tejwani GA; Sheu MJ; Sribanditmongkol P; Satyapriya A
Brain Res; 1998 Jun; 797(2):305-12. PubMed ID: 9666154
[TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems.
Viganò D; Rubino T; Vaccani A; Bianchessi S; Marmorato P; Castiglioni C; Parolaro D
Psychopharmacology (Berl); 2005 Nov; 182(4):527-36. PubMed ID: 16079992
[TBL] [Abstract][Full Text] [Related]
14. Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol.
Romero J; García L; Fernández-Ruiz JJ; Cebeira M; Ramos JA
Pharmacol Biochem Behav; 1995 Aug; 51(4):731-7. PubMed ID: 7675852
[TBL] [Abstract][Full Text] [Related]
15. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.
Oviedo A; Glowa J; Herkenham M
Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305
[TBL] [Abstract][Full Text] [Related]
16. Perinatal delta9-tetrahydrocannabinol exposure reduces proenkephalin gene expression in the caudate-putamen of adult female rats.
Corchero J; García-Gil L; Manzanares J; Fernández-Ruiz JJ; Fuentes JA; Ramos JA
Life Sci; 1998; 63(10):843-50. PubMed ID: 9734704
[TBL] [Abstract][Full Text] [Related]
17. Development of behavioral tolerance to delta 9-THC without alteration of cannabinoid receptor binding or mRNA levels in whole brain.
Abood ME; Sauss C; Fan F; Tilton CL; Martin BR
Pharmacol Biochem Behav; 1993 Nov; 46(3):575-9. PubMed ID: 8278434
[TBL] [Abstract][Full Text] [Related]
18. The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat.
Cox ML; Welch SP
Eur J Pharmacol; 2004 Jun; 493(1-3):65-74. PubMed ID: 15189765
[TBL] [Abstract][Full Text] [Related]
19. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
Boronat MA; Olmos G; García-Sevilla JA
Br J Pharmacol; 1998 Sep; 125(1):175-85. PubMed ID: 9776358
[TBL] [Abstract][Full Text] [Related]
20. Dissociation between morphine-induced spinal gliosis and analgesic tolerance by ultra-low-dose α2-adrenergic and cannabinoid CB1-receptor antagonists.
Grenier P; Wiercigroch D; Olmstead MC; Cahill CM
Behav Pharmacol; 2018 Apr; 29(2 and 3-Spec Issue):241-254. PubMed ID: 29481424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
